Adjustments to reconcile net income (loss) to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Statistical Measurement [Domain] Statistical Measurement [Domain] Schedule of Operating Lease Expense and Measurement Of Lease Liabilities Lease, Cost [Table Text Block] Intangible Asset Amortization Intangible Asset Amortization [Member] Intangible Asset Amortization Cover [Abstract] Cover [Abstract] Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Discount rate Measurement Input, Discount Rate [Member] Schedule of Future Minimum Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Current portion of other liabilities Other Liabilities, Current Equity interest acquired Business Acquisition, Percentage of Voting Interests Acquired Trading Symbol Trading Symbol Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Non-NEOs Non-NEOs [Member] Schedule of Computation of Basic and Diluted Net Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Other Commitments [Line Items] Other Commitments [Line Items] Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Accounts receivable Increase (Decrease) in Accounts Receivable Operating lease liabilities Increase (Decrease) in Operating Lease Liability Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Fair Value Measurements Fair Value Disclosures [Text Block] Proceeds from the exercise of common stock options and employee stock purchases Proceeds from Stock Options Exercised Award Timing Disclosures [Line Items] Other Performance Measure, Amount Other Performance Measure, Amount 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Three Common stock, shares outstanding (in shares) Balance at beginning of period (in shares) Balance at end of period (in shares) Common Stock, Shares, Outstanding Shares available for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Operating lease liabilities, net of current portion Long-term lease liabilities Operating Lease, Liability, Noncurrent Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Current portion of deferred revenue Contract with Customer, Liability, Current Other assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Gross Carrying Amount Finite-Lived Intangible Assets, Gross Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Money Market Funds Money Market Funds [Member] Short-term investments Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Equity Components [Axis] Equity Components [Axis] Award Timing Method Award Timing Method [Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Pension Liability Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Use of Estimates Use of Estimates, Policy [Policy Text Block] Total operating expenses Costs and Expenses Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Adjustment to Compensation, Amount Adjustment to Compensation Amount Value of shares in acquisition consideration Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Additional paid-in capital Additional Paid in Capital, Common Stock Compensation Amount Outstanding Recovery Compensation Amount Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Company Selected Measure Amount Company Selected Measure Amount Tabular List, Table Tabular List [Table Text Block] Weighted Average Weighted Average [Member] Selling and marketing: Selling and Marketing Expense [Member] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Current portion of acquisition-related contingent consideration Business Combination, Contingent Consideration, Liability, Current Issuance of common stock under employee stock purchase plan (ESPP) (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Anti-dilutive potential common shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Purchase of short-term investments Payments to Acquire Held-to-Maturity Securities Operating lease expense Operating Lease, Expense Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Stock-based compensation expense (employee) Adjustments To Additional Paid In Capital, Share Based Compensation, Employee Amount of increase in additional paid-in capital (APIC) resulting from employee stock-based compensation expense. Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Accounts and Financing Receivables [Table] Current assets: Assets, Current [Abstract] Goodwill Goodwill Direct expense Direct Operating Expenses Direct Operating Expenses Payment of taxes on vested restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Percepta product technology Percepta Product Technology [Member] Percepta Technology [Member] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Shares of common stock subject to outstanding options Options Share-Based Payment Arrangement, Option [Member] License fees and royalties Cost Of Revenue, License Fees And Royalties Cost Of Revenue, License Fees And Royalties Fair Value Disclosures [Abstract] 2026 Lessee, Operating Lease, Liability, to be Paid, Year One Net comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Security Exchange Name Security Exchange Name Award Type [Axis] Award Type [Axis] Total liabilities Liabilities Compensation expense Labor and Related Expense Laboratory supplies and reagents expense Cost Of Revenue, Laboratory Supplies And Reagents Expense Cost Of Revenue, Laboratory Supplies And Reagents Expense Allocation of facilities and IT expenses Cost Of Revenue, Allocation Of Facilities And Information Technology Expenses Cost Of Revenue, Allocation Of Facilities And Information Technology Expenses Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Research and development Total research and development Research and Development Expense Expiration Date Trading Arrangement Expiration Date Current portion of operating lease liabilities Less: short-term lease liabilities Operating Lease, Liability, Current Total Shareholder Return Amount Total Shareholder Return Amount Common stock, shares issued (in shares) Common Stock, Shares, Issued Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Concentration risk Concentration Risk, Percentage Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Amortization Of Intangible Assets Amortization Of Intangible Assets [Member] Amortization Of Intangible Assets Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Components of Other Income Other Nonoperating Income and Expense [Text Block] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Research and development: Research and Development Expense [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Acquisition of C2i, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired French research tax credits Other Nonoperating Income (Expense), Foreign Tax Credit Foreign Tax Credit, Nonoperating Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Diluted (in shares) Denominator for diluted EPS — adjusted weighted average shares and assumed conversions (in shares) Weighted Average Number of Shares Outstanding, Diluted Common stock equivalent shares excluded from the dilutive calculation due to antidilutive effect: Antidilutive Securities Excluded From Computation Of Earnings Per Share [Abstract] Antidilutive Securities Excluded From Computation Of Earnings Per Share MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] 2025 remainder of year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Other research and development expenses Other Research and Development Expense Total cost of revenue Cost Of Revenue, Including Amortization Cost Of Revenue, Including Amortization Total stockholders’ equity Balance at beginning of period Balance at end of period Equity, Attributable to Parent Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] C2i developed technology C2i Developed Technology [Member] C2i Developed Technology Other Other Nonoperating Income (Expense), Other Other Nonoperating Income (Expense), Other Investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash payment of contingent consideration for acquisition Payment for Contingent Consideration Liability, Financing Activities Concentration Risk Type [Domain] Concentration Risk Type [Domain] Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Product revenue Product [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Document Fiscal Period Focus Document Fiscal Period Focus All Executive Categories All Executive Categories [Member] Dilutive potential common shares (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Two Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Assets Assets [Abstract] C2i C2i Genomics, Inc. [Member] C2i Genomics, Inc. Document Type Document Type Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Other Income and Expenses [Abstract] Gain (loss) on currency revaluation Other Nonoperating Income (Expense), Foreign Currency Translation Gain (Loss) Foreign Currency Translation Gain (Loss), Nonoperating Schedule of Future Aggregate Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Maximum Maximum [Member] Intangible asset amortization - operating expenses Amortization of Intangible Assets Deferred revenue Contract with Customer, Liability Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Organization, Description of Business and Summary of Significant Accounting Policies Business Description and Accounting Policies [Text Block] Total Finite-Lived Intangible Assets, Net Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accounts payable Accounts Payable, Current Revenue: Revenues [Abstract] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Business Combination Business Combination Disclosure [Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Sample collection expense Cost Of Revenue, Sample Collection Expense Cost Of Revenue, Sample Collection Expense Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Statistical Measurement [Axis] Statistical Measurement [Axis] PEO Name PEO Name Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Probability of achievement Measurement Input, Probability Of Achievement [Member] Measurement input using probability of achievement. Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Award Type [Domain] Award Type [Domain] Name Outstanding Recovery, Individual Name Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Schedule of Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] Non-PEO NEO Non-PEO NEO [Member] Weighted Average Remaining Amortization Period (Years) Finite-Lived Intangible Asset, Useful Life Decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Additional Paid-in Capital Additional Paid-in Capital [Member] Award Timing Predetermined Award Timing Predetermined [Flag] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Medicare Medicare [Member] Represents Medicare. Class of Stock [Line Items] Class of Stock [Line Items] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Other general and administrative expenses Other General and Administrative Expense Class of Stock [Axis] Class of Stock [Axis] Diluted (in USD per share) Diluted EPS (in USD per share) Earnings Per Share, Diluted Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Revenue Recognition and Cost of Revenue Revenue from Contract with Customer [Policy Text Block] Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Issuance of common stock on exercise of stock options and vesting of restricted stock units Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Number of operating segments Number of Operating Segments Cash paid for tax Income Taxes Paid Effect of foreign currency on operations Gain (Loss), Foreign Currency Transaction, before Tax Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Customer [Axis] Customer [Axis] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] US Treasury Bill Securities US Treasury Bill Securities [Member] Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Selling and marketing Total selling and marketing Selling and Marketing Expense Income tax provision (benefit) Income Tax Expense (Benefit) Supplementary cash flow information: Supplemental Cash Flow Information [Abstract] Numerator for diluted EPS — net income (loss) Net Income (Loss) Available to Common Stockholders, Diluted Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Statement of Comprehensive Income [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Income (loss) from operations Operating Income (Loss) Business Acquisition [Line Items] Business Acquisition [Line Items] Number of reporting segments Number of Reportable Segments Total liabilities and stockholders’ equity Liabilities and Equity Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Accrued compensation expenses Employee-related Liabilities, Current Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Schedule of Other Income, net Schedule of Other Nonoperating Income (Expense) [Table Text Block] C2i Inc C2i Inc [Member] C2i Inc Commitments and Contingencies Disclosure [Abstract] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Measurement Input Type [Axis] Measurement Input Type [Axis] Individual: Individual [Axis] Tax portion of vested restricted stock units Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Balance Sheet Related Disclosures [Abstract] Supplies and inventory Total supplies and inventory Inventory, Net Product and Service [Axis] Product and Service [Axis] Entity Address, State or Province Entity Address, State or Province Statement [Line Items] Statement [Line Items] Measurement Input Type [Domain] Measurement Input Type [Domain] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Operating expenses: Operating Expenses [Abstract] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Financial Instruments [Domain] Financial Instruments [Domain] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Acquisition consideration Business Combination, Consideration Transferred Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Contingent consideration expense (reversal of expense) Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Minimum Minimum [Member] Restatement Determination Date Restatement Determination Date Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Right-of-use assets, operating leases Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Stock options and restricted stock units issued and outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Contract manufacturing and testing Biopharmaceutical And Other - Contract Manufacturing And Testing [Member] Biopharmaceutical And Other - Contract Manufacturing And Testing Segments [Axis] Segments [Axis] Number of patents allegedly infringed Loss Contingency, Patents Allegedly Infringed, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Exercise Price Award Exercise Price Net Income (Loss) Per Common Share Earnings Per Share [Text Block] Arrangement Duration Trading Arrangement Duration Other selling and marketing expenses Other Selling and Marketing Expense Issuance of common stock under employee stock purchase plan (ESPP) Stock Issued During Period, Value, Employee Stock Purchase Plan Subsequent Event Subsequent Event [Member] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segments [Domain] Segments [Domain] Biopharmaceutical and other revenue Biopharmaceutical And Other [Member] Represents biopharmaceutical. Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Four All Individuals All Individuals [Member] Allocation of facilities and IT expenses Operating Expenses, Allocation Of Facilities And Information Technology Expenses Operating Expenses, Allocation Of Facilities And IT Expenses Other Testing Revenue Testing, Other [Member] Testing, Other PEO PEO [Member] Income Tax Disclosure [Abstract] Name Trading Arrangement, Individual Name Other income, net  Total Other income, net Other Nonoperating Income (Expense) Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Other assets Increase (Decrease) in Other Noncurrent Assets Pension obligation Defined Benefit Plan, Benefit Obligation Schedule of Third-party Payers as a Percentage of Total Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Other cost Other Cost of Operating Revenue Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Intangible asset amortization - cost of revenue Cost, Amortization Total number of shares reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Concentrations of Credit Risk and Other Risks and Uncertainties Concentrations Of Credit And Other Risks And Uncertainties [Policy Text Block] Disclosure of accounting policy for concentrations of credit risk and other risks and uncertainties. Local Phone Number Local Phone Number Total intangible assets Intangible Assets, Gross (Excluding Goodwill) Noncash lease expense Noncash Lease Expense The noncash portion of lease expense. Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Intangible asset amortization - operating expenses Operating Expenses Deferred tax liabilities Deferred Income Tax Liabilities, Net Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] PEO Total Compensation Amount PEO Total Compensation Amount Shares in acquisition consideration (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Axis] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Accrued liabilities and deferred revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Common Stock Common Stock [Member] Impairment of long-lived assets Impairment loss Impairment, Long-Lived Asset, Held-for-Use Measure: Measure [Axis] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Entity Emerging Growth Company Entity Emerging Growth Company Segment Reporting [Abstract] Entity Central Index Key Entity Central Index Key General and administrative: General and Administrative Expense [Member] Schedule of Supplies and Inventory Schedule of Inventory, Current [Table Text Block] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Thereafter Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Reclassification, Type [Domain] Reclassification, Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Stockholders' Equity Equity [Text Block] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Financial Instrument [Axis] Financial Instrument [Axis] Segment Segment Reporting Disclosure [Text Block] Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Shares of common stock subject to outstanding options Employee And Non Employee Stock Option [Member] An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, number of shares in the entity at a specified price, as defined in the agreement. Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Customers Representing >10% Of Total Revenue Major Customers [Member] Major Customers Revaluation of acquisition-related contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Title Trading Arrangement, Individual Title Decipher product technology Decipher Product Technology [Member] Decipher BioSciences Product Technology Deferred income taxes Other Noncash Deferred Income Tax Expense (Benefit) Other Noncash Deferred Income Tax Expense (Benefit) Statement [Table] Statement [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] City Area Code City Area Code Current liabilities: Liabilities, Current [Abstract] Acquisition-related contingent consideration, net of current portion Business Combination, Contingent Consideration, Liability Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Change in currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Total current assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Prosigna product technology Prosigna Product Technology [Member] Prosigna Product Technology Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Reclassification, Type [Axis] Reclassification, Type [Axis] Income Taxes Income Tax Disclosure [Text Block] 2029 Lessee, Operating Lease, Liability, to be Paid, Year Four Earnings (loss) per share: Earnings Per Share [Abstract] Equity [Abstract] Accumulated deficit Retained Earnings (Accumulated Deficit) Class of Stock [Domain] Class of Stock [Domain] Revenue Revenue from Contract with Customer Benchmark [Member] Deposits Deposits for leases Security Deposit Supplies and inventory Increase (Decrease) in Inventories General and administrative Total general and administrative General and Administrative Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Discount rate Operating Lease, Weighted Average Discount Rate, Percent Present value of future lease payments Operating Lease, Liability Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Underlying Securities Award Underlying Securities Amount Amendment Flag Amendment Flag Entity Registrant Name Entity Registrant Name Loss on disposal of property, plant and equipment Gain (Loss) on Disposition of Property Plant Equipment Supplies Other Inventory, Supplies, Gross Operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Depreciation and amortization Depreciation, Depletion and Amortization Interest income Other Nonoperating Income (Expense), Interest Income Other Nonoperating Income (Expense), Interest Income Gross profit Gross Profit Fair Value as of Grant Date Award Grant Date Fair Value Customer Concentration Risk Customer Concentration Risk [Member] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Schedule of Revenue Disaggregation of Revenue [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date: Restatement Determination Date [Axis] Title of 12(b) Security Title of 12(b) Security Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock, $0.001 par value; 125,000,000 shares authorized, 78,306,356 and 77,772,678 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively Common Stock, Value, Issued Additional cash to be paid Business Combination, Contingent Consideration, Cash To Be Paid Business Combination, Contingent Consideration, Cash To Be Paid Stock-based compensation expense (ESPP) Adjustments To Additional Paid In Capital, Share Based Compensation, ESPP Amount of increase in additional paid-in capital (APIC) resulting from ESPP stock-based compensation expense. Issuance of common stock and options for acquisition Stock Issued During Period, Value, Acquisitions Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Issuance of common stock and options for acquisition (in shares) Stock Issued During Period, Shares, Acquisitions Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of March 31, 2025 and December 31, 2024 Preferred Stock, Value, Issued Inventory Inventory, Finished Goods, Gross Employee stock purchase plan Common stock available for the Employee Stock Purchase Plan Employee Stock [Member] Basic (in USD per share) Basic EPS (in USD per share) Earnings Per Share, Basic Accounts payable Increase (Decrease) in Accounts Payable Decipher trade names Decipher Trade Names [Member] Decipher Trade Names Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Property, plant and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Purchases of property, plant and equipment included in accounts payable and accrued liability Capital Expenditures Incurred but Not yet Paid Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Numerator for basic EPS — net income (loss) Net Income (Loss) Available to Common Stockholders, Basic Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Robert Epstein [Member] Robert Epstein Total assets Assets Product costs Cost of Goods and Services Sold 2026 Finite-Lived Intangible Asset, Expected Amortization, Year One Maximum contingent consideration to be paid Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment NanoString NanoString [Member] Represents NanoString. Other liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Short term investments fair value Debt Securities, Held-to-Maturity, Fair Value Commitments and contingencies Commitments and Contingencies Termination Date Trading Arrangement Termination Date Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Testing revenue Testing [Member] Represents testing. 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two Short-term investments, allowance for expected credit losses Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest Entity Address, City or Town Entity Address, City or Town Net income (loss) Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Other Commitments [Table] Other Commitments [Table] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Business Acquisition [Axis] Business Acquisition [Axis] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Entity File Number Entity File Number Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Shares used to compute earnings (loss) per common share: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Entity Address, Address Line Two Entity Address, Address Line Two Effect of foreign currency on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Accrued other Other Accrued Liabilities, Current Name Forgone Recovery, Individual Name Remainder of 2024 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Document Period End Date Document Period End Date Short-Term Investments Investment, Policy [Policy Text Block] Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Insider Trading Arrangements [Line Items] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Schedule of Reserved Shares of Common Stock for Issuance Schedule of Stock by Class [Table Text Block] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Compensation expense Cost Of Revenue, Compensation Expense Cost Of Revenue, Compensation Expense Effect of potentially dilutive common stock from: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Cost of revenue Cost of revenue Cost of Revenue Adjustment to Compensation: Adjustment to Compensation [Axis] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Accounts Receivable Accounts Receivable [Member] Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Restricted cash Restricted Cash and Cash Equivalents, Noncurrent Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Customer [Domain] Customer [Domain] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Accumulated Deficit Retained Earnings [Member] Restricted cash Restricted Cash and Cash Equivalents Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Basic (in shares) Denominator for basic EPS — weighted average shares (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Restricted stock units Restricted Stock Units (RSUs) [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Name Awards Close in Time to MNPI Disclosures, Individual Name UnitedHealthcare United Healthcare [Member] Represents United Healthcare. Biopharmaceutical revenue Biopharmaceutical And Other - Biopharmaceutical Revenue [Member] Biopharmaceutical And Other - Biopharmaceutical Revenue Reportable Segment Reportable Segment [Member] Reportable Segment Entity Filer Category Entity Filer Category Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Cost of revenue: Cost of Revenue [Abstract] Company Selected Measure Name Company Selected Measure Name